Skip to main content
Log in

Medikation über die Lunge

Hintergründe der Aerosolmedizin

  • Fortbildung
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

1

© S. Canisius, nach [5]

2

© S. Canisius, nach [5]

3

© aus [1]

4

© aus [1]

Literatur

  1. Scheuch G, Siekmeier R. Novel Approaches to Enhance Pulmonary Delivery of Proteins and Peptides. J Physiol Pharmacol. 2007;58 Suppl 5(Pt 2):615-25

  2. Siekmeier R, Scheuch G. Treatment of Systemic Diseases by Inhalation of Biomolecule Aerosols. J Physiol Pharmacol. 2009;60 Suppl 5:15-26

  3. [No authors listed] Human Respiratory Tract Model for Radiological Protection. A Report of a Task Group of the International Commission on Radiological Protection. Ann ICRP. 1994;24(1-3):1-482

  4. Scheuch G, Stahlhofen W. Deposition and Dispersion of Aerosols in the Airways of the Human Respiratory Tract: The Effect of Particle Size. Exp Lung Res. 1992;18(3):343-58

  5. Canisius S, Scheuch G. Grundlagen der Aerosoltherapie. Atemwegs Lungenkr. 2016;42(10):481-6

  6. Niven R W. Delivery of Biotherapeutics by Inhalation Aerosol. Crit Rev Ther Drug Carrier Syst. 1995;12(2-3):151-231

  7. Wolff RK. Safety of Inhaled Proteins for Therapeutic Use. J Aerosol Med. 1998;11(4):197-219

  8. Bennett WD. Controlled Inhalation of Aerosolised Therapeutics. Expert Opin Drug Deliv. 2005;2(4):763-7

  9. Olsson B, Kassinos SC. On the Validation of Generational Lung Deposition Computer Models Using Planar Scintigraphic Images: The Case of Mimetikos Preludium. J Aerosol Med Pulm Drug Deliv. 2021;34(2):115-2

  10. Kohlhäufl M, Brand P, Meyer T et al. Detection of Impaired Intrapulmonary Convective Mixing by Aerosol Bolus Dispersion in Patients with Emphysema. Eur J Med Res. 1997; 2 (3): 121-8

  11. Kohlhäufl M, Brand P, Selzer et al. Diagnosis of Emphysema in Patients with Chronic Bronchitis: A New Approach. Eur Respir J. 1998; 12 (4): 793-98

  12. Kohlhäufl M, Brand P, Scheuch G et al. Increased Fine Particle Deposition in Women with Asymptomatic Nonspecific Airway Hyperresponsiveness. Am J Respir Crit Care Med. 1999;159 (3): 902-6

  13. Kohlhäufl M, Brand P, Rock C et al. Noninvasive Diagnosis of Emphysema. Aerosol Morphometry and Aerosol Bolus Dispersion in Comparison to HRCT. Am J Respir Crit Care Med. 1999;160(3):913-8

  14. Kohlhäufl M, Brand P, Scheuch G et al. Aerosol Morphometry and Aerosol Bolus Dispersion in Patients with CT-Determined Combined Pulmonary Emphysema and Lung Fibrosis. J Aerosol Med. 2000;13(2):117-24

  15. Vogelmeier C, Kardos P, Hofmann T et al. Nebulised budesonide using a novel device in patients with oral steroid-dependent asthma. Eur Respir J. 2015;45(5):1273-82

  16. Brand P, Beckmann H, Maas Enriquez M et al. Peripheral Deposition of 1-Protease Inhibitor Using Commercial Inhalation Devices. Eur Respir J. 2003;22(2):263-7

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sebastian Canisius.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Canisius, S. Hintergründe der Aerosolmedizin. Pneumo News 13, 35–39 (2021). https://doi.org/10.1007/s15033-021-2781-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-021-2781-1

Navigation